Feedback / Questions
AUG-3387 - TFF Pharma, Augmenta Bioworks
https://www.globenewswire.com/news-release/2021/06/22/2250916/0/en/Augmenta-Bioworks-and-TFF-Pharmaceuticals-Announce-Selection-of-Lead-Monoclonal-Antibody-Candidate-AUG-3387-for-Clinical-Development-Against-COVID-19.html
Jun 22, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev